The Significance of MRI in the Development of Diagnostics and Treatment of Breast Cancer

Mammary Ductal Carcinoma Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01484704
• Other study ID #: 63/180/2010
• Status: Recruiting
• Phase: N/A
• First received: November 30, 2011
• Last updated: December 1, 2011
• Start date: February 2011

Study information

• Verified date: November 2011
• Source: Turku University Hospital
• Contact: Nina M Brück, MD
• Phone: +35823130544
• Email: nina.bruck[@]tyks.fi
• Is FDA regulated: No
• Health authority: Finland: Ethics Committee
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine how MRI changes the treatment and diagnostics of ductal breast cancer. 100 women with newly diagnosed breast cancer will participate the study.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Tumor size less than 2cm

• Ductal carcinoma unifocal

Exclusion Criteria:

• Previous breast cancer

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Carcinoma, Ductal
• Carcinoma, Ductal, Breast
• Mammary Ductal Carcinoma

Locations

Country	Name	City	State
Finland	University hospital of Turku	Turku

Sponsors (1)

Lead Sponsor	Collaborator
Turku University Hospital

Country where clinical trial is conducted

Finland,